Atlas Trials

Yeon Hee Park

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Yeon Hee Park

RecordFirmDate
Fulvestrant With Ribociclib Versus Physician's Choice Treatments Recurred After Completion of Adjuvant Cyclin-Dependent Kinase 4/6 Inhibitors in HR+, HER2- Metastatic Breast Cancer (NCT06849947)Yeon Hee Park2026-02-01
NEPA in Patients With HER2-positive or HER2-low Advanced Breast Cancer Treated With T-DXd (NCT07132749)Yeon Hee Park2025-08-12
Prevention of Sacituzumab Govitecan-related Neutropenia in Patients With Metastatic Triple Negative Breast Cancer (NCT06616987)Yeon Hee Park2025-07-03

Track Yeon Hee Park automatically

Every clearance here is in the API, with alerts when new ones post.